One of NNE Pharmaplan’s latest exciting news is that last year you established offices to accommodate your existing customers in Belgium. What were the strategic motivations for establishing a presence in Belgium? Since NNE Pharmaplan concentrates on providing services based on our pharmaceutical and life sciences heritage, which we have…
Grünenthal GmbH You have been with Grünenthal since 2004 and as the Austria Country Manager since June 2012. What were your initial goals when you took up the position and how have they panned out so far? I wanted to make a change — a change for patients; a change for those…
Takeda Pharma GmbH Can you give our readers a snapshot of the scope of Takeda’s operations and the organizational structure within Austria? Takeda in Austria is a top-ten player with a turnover of roughly €80 million, according to IMS figures. In primary care markets we focus on core therapeutic areas such as cardiovascular…
Aldimed As a means of introduction, could you please describe the origins of ALDIMED, how it started, its development the past couple of years and where it stands today? ALDIMED represents the medical technology industry in Latin America; this is a Colombian initiative and one of its founders. The Executive Board…
AbbVie Austria You have had an extensive career at the company, since 1989. What does the company have to offer that has made you stay so long and dedicated? AbbVie is a global biopharmaceutical company, which as of January 2nd is being traded on the New York Stock Exchange as an independent…
Belgium Mr. Heyman, you inherited the chair and management of Janssen Pharmaceutica. What core values and spirit of Dr. Paul Janssen were you asked by the Janssen family to perpetuate throughout the years? Tom Heyman (TH): Janssen Pharmaceutica is all about innovation—developing, producing and providing innovative healthcare solutions for patients. When…
Janssen Pharmaceutica Mr. Heyman, you inherited the chair and management of Janssen Pharmaceutica. What core values and spirit of Dr. Paul Janssen were you asked by the Janssen family to perpetuate throughout the years? Tom Heyman: Janssen Pharmaceutica is all about innovation—developing, producing and providing innovative healthcare solutions for patients. When I…
Can you please introduce us to Dalkia? Pat Gilroy: Dalkia is a multinational company that operates in over 40 countries throughout the world and turns over 8Bn EUR annually. We are the energy management and utilities services subsidiary of Veolia Environment and Électricité de France. Dalkia formed a subsidiary in…
Rottapharm Ireland Mr. Garrahy, can you please begin by introducing yourself and this production facility to our readers? I joined Rottapharm in 1998, when the organization decided to establish its Dublin production facility. Prior to that, I was a plant manager for Warner Lambert in Cork. When I took on this role,…
Vela Laboratories Prior to founding Vela, you worked in a number of different positions with various companies such as Baxter and Octapharma. What opportunities did you see in founding your own company? The opportunity to found Vela arose while working at Igeneon, when upper management there filed insolvency and liquidator takes care…
Eucodis Bioscience Previously you worked for a pharmaceutical company, before moving to head up Eucodis Bioscience. What was your main motivation for switching from the pharmaceutical to the industrial biotech industry? The main motivation was the portfolio of the company and that it is in biotech. Austria is not a big country…
Boston Consulting Group Austria Could you please provide an overview of your main scope of activities in Austria and the importance of healthcare and pharmaceuticals to Boston Consulting Group’s (BCG) business model and revenue? EK: BCG has been in Austria for 15 years and we are integrated into the German-Austrian system, meaning that many…
See our Cookie Privacy Policy Here
